0001144204-12-020647.txt : 20120409
0001144204-12-020647.hdr.sgml : 20120409
20120409090120
ACCESSION NUMBER: 0001144204-12-020647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120405
FILED AS OF DATE: 20120409
DATE AS OF CHANGE: 20120409
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tarnok Michael P.
CENTRAL INDEX KEY: 0001413525
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 12748889
BUSINESS ADDRESS:
BUSINESS PHONE: (212) 531-5965
MAIL ADDRESS:
STREET 1: KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
v308708_4.xml
OWNERSHIP DOCUMENT
X0305
4
2012-04-05
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001413525
Tarnok Michael P.
KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
1
0
0
0
Common Stock
2012-04-05
4
P
0
17500
1.55
A
278600
D
Of the 278,600 shares, 25,000 are shares of restricted stock.
/s/ James F. Oliviero, III, Attorney-in-Fact
2012-04-05